These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6868023)

  • 1. Evaluation of thrombogenicity of beta-propiolactone/ultraviolet (beta-PL/UV) treated PPSB in chimpanzees.
    Kotitschke R; Stephan W; Prince AM; Brotman B
    Thromb Res; 1983 May; 30(3):235-44. PubMed ID: 6868023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term tolerance and recovery of beta-propiolactone/ultraviolet (beta PL/UV) treated PPSB in chimpanzees.
    Stephan W; Kotitschke R; Prince AM; Brotman B
    Thromb Haemost; 1981 Aug; 46(2):511-4. PubMed ID: 7302890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the hepatitis safety of a beta-propiolactone/ultraviolet treated factor IX concentrate (PPSB).
    Heinrich D; Kotitschke R; Berthold H
    Thromb Res; 1982 Oct; 28(1):75-83. PubMed ID: 7157232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of betapropiolactone/ultraviolet irradiation (BPL/UV) treatment of source plasma on hepatitis transmission by factor IX complex in chimpanzees.
    Prince AM; Stephan W; Brotman B; van den Ende MC
    Thromb Haemost; 1980 Dec; 44(3):138-42. PubMed ID: 7466740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the Hutchinson strain of non-A, non-B hepatitis virus by combined use of beta-propiolactone and ultraviolet irradiation.
    Prince AM; Stephan W; Dichtelmüller H; Brotman B; Huima T
    J Med Virol; 1985 Jun; 16(2):119-25. PubMed ID: 3925077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined treatment of serum containing hepatitis B virus with beta-propiolactone and ultraviolet irradiation.
    Stephan W; Berthold H; Prince AM
    Vox Sang; 1981 Sep; 41(3):134-8. PubMed ID: 7331286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
    Heinrich D; Sugg U; Brackmann HH; Stephan W; Lissner R
    Dev Biol Stand; 1987; 67():311-7. PubMed ID: 3649316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-propiolactone/ultraviolet irradiation: a review of its effectiveness for inactivation of viruses in blood derivatives.
    Prince AM; Stephan W; Brotman B
    Rev Infect Dis; 1983; 5(1):92-107. PubMed ID: 6828813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the Hutchinson strain of hepatitis non-A, non-B virus in intravenous immunoglobulin by beta-propiolactone.
    Stephan W; Dichtelmüller H; Prince AM; Brotman B; Huima T
    J Med Virol; 1988 Nov; 26(3):227-32. PubMed ID: 3144576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
    Prince AM; Stephan W; Kotitschke R; Brotman B
    Thromb Haemost; 1983 Aug; 50(2):534-6. PubMed ID: 6415846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII concentrate from cold sterilized human plasma.
    Stephan W; Prince AM; Kotitschke R
    Dev Biol Stand; 1983; 54():491-5. PubMed ID: 6418593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
    Stephan W
    Curr Stud Hematol Blood Transfus; 1989; (56):122-7. PubMed ID: 2642784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-propiolactone for the inactivation of non-A/non-B type 1 hepatitis virus capable of inducing cytoplasmic tubular ultrastructures in chimpanzees.
    Yoshizawa H; Itoh Y; Iwakiri S; Kitajima K; Noguchi Y; Tachibana K; Nakamura T; Miyakawa Y; Mayumi M
    Vox Sang; 1984; 46(2):86-91. PubMed ID: 6422638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tolerance of beta-propiolactone-treated and UV-irradiated rat serum].
    Sonneborn HH; Stephan W
    Infusionsther Klin Ernahr; 1980 Jun; 7(3):145-7. PubMed ID: 7191834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biotest position on HIV-1 seroconversions in 1990 in 11 patients, treated with beta-propiolactone/uv virus inactivated PPSB].
    Pustoslemsek P; Kloft M; Kotitschke R
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):344-6. PubMed ID: 8142739
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivation of non-A, non-B virus infectivity by a beta propiolactone/ultraviolet irradiation treatment and Aerosil adsorption procedure used for preparation of a stabilized human serum.
    Prince AM; Stephan W; Brotman B
    Vox Sang; 1984; 46(2):80-5. PubMed ID: 6322448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of HIV in plasma derivatives by beta-propiolactone and UV irradiation.
    Dichtelmüller H; Stephan W; Prince AM; Gürtler L; Deinhardt F
    Infection; 1987; 15(5):367-9. PubMed ID: 3121517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BETA-PROPIOLACTONE PLUS ULTRAVIOLET IRRADIATED PLASMA. A CLINICAL EVALUATION FOR HEPATITIS, TOXICITY AND ALLERGY.
    WOLFRAM BR; LOGRIPPO GA
    Bibl Haematol; 1964; 19():644-7. PubMed ID: 14267084
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of combined beta-propiolactone/ultraviolet irradiation treatment on hepatitis B virus.
    Prince AM; Stephan W
    Lancet; 1980 Oct; 2(8200):917. PubMed ID: 6107566
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation of factor VII concentrate using CNBr-activated Sepharose 4B immunoaffinity chromatography.
    Mousavi Hosseini K; Nasiri S
    Med J Islam Repub Iran; 2015; 29():170. PubMed ID: 26034723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.